V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 310002954 | 310001262 | 1.58 | null | Adjuvant (A) | 2014-11-06 | 2014-11-09 | CISPLATIN + GEMCITABINE | 02 | N | 310016733 | CISPLATIN + GEMCITABINE |
| 310002955 | 310011649 | 1.88 | null | Palliative (P) | 2014-12-24 | 2014-12-26 | DOXORUBICIN | 2 | null | 310016758 | DOXORUBICIN |
| 310002956 | 310011649 | 1.6 | 55 | Palliative (P) | null | 2019-01-30 | Ipilimumab | 2 | N | 310016758 | IPILIMUMAB |
| 310002957 | 310011649 | null | 85 | Curative (C) | 2017-07-05 | 2017-07-28 | Retinoblastoma JOE | N | Y | 310016758 | CEV |
| 310002958 | 310001263 | 1.59 | 80.6 | Adjuvant (A) | 2017-03-05 | 2017-03-07 | Cisplatin + Gemcitabine (D 1 & 8) | N | N | 310016762 | CISPLATIN + GEMCITABINE |
| 310002960 | 310008975 | 1.64 | null | null | 2013-03-13 | 2013-03-29 | CHOP R - 21 days | N | N | 310016775 | CHOP R |
| 310002961 | 310001264 | 1.7 | 89.8 | Curative (C) | 2016-06-25 | 2016-07-16 | CHOP R - 14 days | null | N | 310016776 | CHOP R |
| 310002962 | 310001264 | 1.62 | 61.5 | Palliative (P) | 2017-07-26 | 2017-07-26 | CISPLATIN + GEMCITABINE | null | N | 310016776 | CISPLATIN + GEMCITABINE |
| 310002963 | 310001264 | 1.63 | 62.5 | Adjuvant (A) | 2017-03-29 | 2017-04-20 | Trial Unspecified | Y | N | 310016776 | TRIAL |
| 310002964 | 310001264 | 1.52 | 72 | Curative (C) | null | 2013-08-31 | Cisplatin 7 day | 02 | null | 310016776 | CISPLATIN |
| 310002965 | 310001264 | 1.77 | 54.4 | Palliative (P) | 2015-09-05 | 2015-09-09 | Cisplatin + Gemcitabine (D 1 & 8) | N | N | 310016776 | CISPLATIN + GEMCITABINE |
| 310002966 | 310011419 | 1.77 | 119 | Palliative (P) | 2015-03-09 | 2015-03-12 | GO2 TRIAL | Y | N | 310016795 | TRIAL |
| 310002967 | 310001265 | 1.65 | 61.4 | Palliative (P) | 2014-05-18 | 2014-06-01 | CISPLATIN + GEMCITABINE | 02 | N | 310016797 | CISPLATIN + GEMCITABINE |
| 310002968 | 310006498 | 1.87 | 82 | Palliative (P) | 2018-05-01 | 2018-05-02 | PEMBROLIZUMAB | 02 | N | 310016799 | PEMBROLIZUMAB |
| 310002969 | 310006498 | 1.47 | 75.8 | Curative (C) | 2014-09-26 | 2014-09-27 | Cisplatin 7 day | 02 | Y | 310016799 | CISPLATIN |
| 310002970 | 310006498 | 1.59 | 54.9 | Palliative (P) | 2016-04-17 | 2016-04-23 | Cisplatin + Gemcitabine (D 1 & 8) | null | N | 310016799 | CISPLATIN + GEMCITABINE |
| 310002971 | 310006498 | null | 80.3 | Curative (C) | 2015-07-22 | 2015-07-22 | Retinoblastoma JOE | N | N | 310016799 | CEV |
| 310002972 | 310001266 | 1.74 | 75.2 | Palliative (P) | 2015-07-14 | 2015-07-18 | Carboplatin + Etoposide iv&po | N | null | 310016811 | CARBOPLATIN + ETOPOSIDE |
| 310002973 | 310001267 | 1.71 | 63 | Palliative (P) | 2014-09-01 | 2014-09-07 | PEMBROLIZUMAB | 02 | N | 310016815 | PEMBROLIZUMAB |
| 310002974 | 310001268 | 1.89 | 88.1 | Palliative (P) | 2015-01-07 | 2015-01-19 | Cisplatin | null | Y | 310016821 | CISPLATIN |
| 310002975 | 310001269 | null | 59.1 | Curative (C) | 2015-04-14 | 2015-04-26 | Retinoblastoma JOE | N | N | 310016833 | CEV |
| 310002976 | 310001269 | 1.68 | 57.3 | Palliative (P) | 2018-04-24 | 2018-05-02 | Cisplatin + Gemcitabine (D 1 & 8) | N | N | 310016833 | CISPLATIN + GEMCITABINE |
| 310002977 | 310001270 | 1.63 | null | Palliative (P) | 2018-09-04 | 2018-09-20 | Ipilimumab | 02 | N | 310016842 | IPILIMUMAB |
| 310002978 | 310001271 | 1.67 | 62 | Neo-adjuvant (N) | 2016-01-24 | 2016-01-27 | Cisplatin + Gemcitabine (D 1 & 8) | 02 | null | 310016844 | CISPLATIN + GEMCITABINE |
| 310002979 | 310001272 | 1.47 | 89.1 | Curative (C) | 2018-01-22 | 2018-01-26 | Cisplatin | 02 | Y | 310016845 | CISPLATIN |
| 310002980 | 310001272 | 1.73 | 89.4 | null | 2016-03-02 | 2016-03-12 | CHEMO-T TRIAL | 1 | N | 310016845 | TRIAL |
| 310002981 | 310001273 | 1.49 | null | Palliative (P) | 2013-04-02 | 2013-04-02 | PEMBROLIZUMAB | 02 | null | 310016854 | PEMBROLIZUMAB |
| 310002982 | 310001274 | 1.74 | 110.5 | Palliative (P) | null | 2017-06-25 | Ipilimumab | N | N | 310016855 | IPILIMUMAB |
| 310002983 | 310006501 | 1.75 | 79.1 | Curative (C) | 2016-01-01 | 2016-01-05 | CHOP R - 21 days | Y | N | 310016856 | CHOP R |
| 310002984 | 310001275 | 1.6 | 67.7 | Palliative (P) | 2015-09-06 | 2015-09-07 | Trial Unspecified | Y | N | 310016868 | TRIAL |
| 310002985 | 310001275 | null | 112.9 | Curative (C) | 2013-02-19 | 2013-02-24 | CHOP R - 21 days | 02 | N | 310016868 | CHOP R |
| 310002986 | 310001275 | 1.59 | 77.3 | Curative (C) | 2013-04-16 | 2013-04-18 | Cisplatin | 02 | N | 310016868 | CISPLATIN |
| 310002987 | 310001275 | 1.56 | 81 | Curative (C) | 2013-07-05 | 2013-07-31 | Cisplatin 7 day | N | Y | 310016868 | CISPLATIN |
| 310002988 | 310001275 | 1.72 | 74.5 | null | 2017-02-20 | 2017-02-20 | Cisplatin + Gemcitabine (D 1 & 8) | 2 | N | 310016868 | CISPLATIN + GEMCITABINE |
| 310002989 | 310001275 | null | 79.5 | Curative (C) | 2014-09-07 | 2014-09-17 | CHOP R - 21 days | 2 | N | 310016868 | CHOP R |
| 310002990 | 310001275 | null | 57 | Palliative (P) | 2016-09-19 | 2016-09-19 | Ipilimumab | 02 | N | 310016868 | IPILIMUMAB |
| 310002991 | 310001276 | 1.52 | 86.7 | Curative (C) | 2013-05-06 | 2013-05-07 | Cisplatin | 02 | Y | 310016886 | CISPLATIN |
| 310002992 | 310001276 | null | 80.3 | Curative (C) | null | 2013-10-18 | Cisplatin | null | Y | 310016886 | CISPLATIN |
| 310002993 | 310001276 | null | 84.3 | Adjuvant (A) | 2014-12-27 | 2014-12-30 | Retinoblastoma JOE | null | N | 310016886 | CEV |
| 310002994 | 310001276 | 1.73 | 97.2 | Neo-adjuvant (N) | 2018-06-08 | 2018-06-11 | Cisplatin + Gemcitabine (D 1 & 8) | N | N | 310016886 | CISPLATIN + GEMCITABINE |
| 310002995 | 310001276 | 1.72 | 95.2 | Palliative (P) | 2017-08-28 | 2017-09-07 | PEMBROLIZUMAB | 02 | N | 310016886 | PEMBROLIZUMAB |
| 310002996 | 310001276 | 1.53 | 50.5 | null | 2016-04-11 | 2016-04-17 | CISPLATIN + GEMCITABINE | N | N | 310016886 | CISPLATIN + GEMCITABINE |
| 310002997 | 310001276 | null | 66.8 | Palliative (P) | 2015-08-18 | 2015-09-25 | Ipilimumab | 2 | N | 310016886 | IPILIMUMAB |
| 310002998 | 310001276 | 1.63 | 130.9 | Palliative (P) | 2015-06-15 | 2015-06-16 | CARBOPLATIN + ETOPOSIDE | N | N | 310016886 | CARBOPLATIN + ETOPOSIDE |
| 310002999 | 310001276 | 1.62 | 7 | Palliative (P) | 2016-03-11 | 2016-03-12 | Ipilimumab | 02 | N | 310016886 | IPILIMUMAB |
| 310003000 | 310001277 | null | 112.4 | Palliative (P) | 2018-06-13 | 2018-07-12 | PEMBROLIZUMAB | N | N | 310016914 | PEMBROLIZUMAB |
| 310003001 | 310006504 | 1.64 | null | Palliative (P) | 2016-05-18 | 2016-05-26 | Ipilimumab | 02 | N | 310016916 | IPILIMUMAB |
| 310003002 | 310001278 | 1.64 | 65.4 | Palliative (P) | 2014-12-27 | 2015-01-10 | Ipilimumab | 02 | N | 310016917 | IPILIMUMAB |
| 310003003 | 310001278 | 1.63 | 56.7 | Curative (C) | 2014-04-06 | 2014-04-06 | CHOP R | 02 | N | 310016917 | CHOP R |
| 310003004 | 310001279 | 1.68 | 85 | null | 2017-10-04 | 2017-10-04 | PEMBROLIZUMAB | 02 | N | 310016921 | PEMBROLIZUMAB |